Geo News
Community curated by people like you
Latest
AI
Crypto
Health
World Affairs
US Politics
Updated: AstraZeneca sees blockbuster sales for Claudin 18.2 ADC but Ultomiris flops in rare disease — Endpoints
Updated: AstraZeneca sees blockbuster sales for Claudin 18.2 ADC but Ultomiris flops in rare disease
Endpoints
View source article
Featured Stories
OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns
Aug 7, 2026
·
2 sources
Updated: AstraZeneca sees blockbuster sales for Claudin 18.2 ADC but Ultomiris flops in rare disease — Endpoints